← Open Payments lookup

FATMA AHMOUDA: Open Payments

NPI 1982311718 · FULTON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,492 in 178 payments from 13 companies in 2025. Trend: 2023 $154 · 2024 $842 · 2025 $2,492

Food & beverage: $2,461Education: $31
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.30$392
Alkermes, Inc.36$336
Vanda Pharmaceuticals Inc.12$296
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)30$296
Otsuka America Pharmaceutical, Inc.12$185
Janssen Pharmaceuticals, Inc13$182
Teva Pharmaceuticals USA, Inc.10$164
Axsome Therapeutics, Inc.7$162
ABBVIE INC.11$160
Supernus Pharmaceuticals, Inc.9$147

Products named: INGREZZA, ARISTADA, FANAPT, CAPLYTA, INVEGA SUSTENNA, Auvelity, REXULTI, VRAYLAR.

Industry payments across MO — which companies pay providers there.